For Immediate Release: November 16, 2021 The U.S. Food and Drug Administration today authorized marketing of EaseVRx, a prescription-use immersive virtual reality (VR) system that uses cognitive behavioral therapy and other behavioral methods to help with …
FDA News Release Agency Details Test Priorities and Takes Steps Regarding the Appropriate Oversight of Tests For Immediate Release: November 15, 2021 Today, the U.S. Food and Drug Administration is taking several important actions to support ongoing …
FDA News Release Treatment is First FDA-Approved Option Patients Can Take Regardless of Previous Therapies For Immediate Release: November 12, 2021 Today, the U.S. Food and Drug Administration approved Besremi (ropeginterferon alfa-2b-njft) injection to …
For Immediate Release: November 12, 2021 Today, the U.S. Food and Drug Administration is providing an update related to the June 14, 2021, recall of certain Philips Respironics ventilators, continuous positive airway pressure (CPAP) and bilevel positive …
For Immediate Release: November 12, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On November 9, 2021, the FDA posted an updated Molecular and Antigen Home …
For Immediate Release: October 29, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On Friday, October 22, 2021, Acting FDA Commissioner Janet Woodcock, M.D. and …
For Immediate Release: October 29, 2021 Español Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The …
For Immediate Release: October 27, 2021 The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for the 30 million …
For Immediate Release: October 27, 2021 Today, the U.S. Food and Drug Administration took several new actions to strengthen breast implant risk communication and help those who are considering breast implants make informed decisions. First, the agency …
For Immediate Release: October 27, 2021 The following quote is attributed to Bakul Patel, director of the FDA’s Digital Health Center of Excellence in the Center for Devices and Radiological Health “With artificial intelligence and machine learning …
For Immediate Release: October 26, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA authorized the 10th over-the-counter (OTC) COVID-19 test, reissued …
For Immediate Release: October 25, 2021 The following quote is attributed to Linda Katz, director of the FDA's Office of Cosmetics and Colors: “The FDA remains dedicated to keeping consumers safe from contaminated cosmetic products. As part of these …
For Immediate Release: October 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA began posting materials for the next Vaccine and Related …
For Immediate Release: October 20, 2021 The following quote is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response “The FDA, along with the CDC and our state and local partners, is working to investigate a multistate outbreak …
For Immediate Release: October 20, 2021 Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 …
For Immediate Release: October 20, 2021 A dietary supplement manufacturer and its two owners have been ordered by a federal court to stop selling products until they come into compliance with federal regulations and requirements under the Federal Food, …
For Immediate Release: October 19, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On Oct. 12, the FDA approved an abbreviated new drug application for propofol …
FDA News Release Data Show Youth, Non-Smokers, and Former Smokers Are Unlikely to Initiate or Reinitiate Tobacco Use with These Products For Immediate Release: October 19, 2021 Today, the U.S. Food and Drug Administration announced it has authorized the …
For Immediate Release: October 19, 2021 Today, the U.S. Food and Drug Administration issued a landmark proposal intended to improve access to and reduce the cost of hearing aid technology for millions of Americans. The agency proposed a rule to establish …
FDA News Release Second Interchangeable Biosimilar Product Approved by Agency For Immediate Release: October 18, 2021 The U.S. Food and Drug Administration approved the first interchangeable biosimilar product to treat certain inflammatory diseases. …
03 days 20:07:26
